INARI MED INC's ticker is NARI and the CUSIP is 45332Y109. A total of 256 filers reported holding INARI MED INC in Q1 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $2,192,017 | +171.6% | 35,504 | +179.6% | 0.01% | +120.0% |
Q4 2022 | $807,085 | -48.8% | 12,698 | -34.6% | 0.01% | -44.4% |
Q3 2021 | $1,575,000 | -43.6% | 19,421 | -35.1% | 0.01% | -43.8% |
Q2 2021 | $2,791,000 | +1020.9% | 29,918 | +728.3% | 0.02% | +700.0% |
Q3 2020 | $249,000 | – | 3,612 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Affinity Asset Advisors, LLC | 125,000 | $11,409,000 | 4.14% |
SECTORAL ASSET MANAGEMENT INC | 163,550 | $14,927,000 | 2.25% |
Lisanti Capital Growth, LLC | 81,460 | $7,435,000 | 1.08% |
Pier Capital, LLC | 99,422 | $9,074,000 | 0.96% |
Beck Bode, LLC | 33,384 | $3,047,000 | 0.76% |
Nicholas Investment Partners, LP | 104,932 | $9,577,000 | 0.61% |
CNA FINANCIAL CORP | 24,773 | $2,261,000 | 0.59% |
NEXT CENTURY GROWTH INVESTORS LLC | 56,523 | $5,158,000 | 0.46% |
HARBOURVEST PARTNERS LLC | 38,540 | $3,518,000 | 0.45% |
Birchview Capital, LP | 7,000 | $639,000 | 0.41% |